Indemnification Agreements
Biotechnology
Biotechnology (599) | Indemnification Agreements (8,210)
- 4D Molecular Therapeutics Inc (1 contract)
- 89bio, Inc. (1)
- ABEONA THERAPEUTICS INC. (2)
- ACCELERON PHARMA INC (1)
- Accustem Sciences Inc. (1)
- Achaogen, Inc. (1)
- ACHIEVE LIFE SCIENCES, INC. (1)
- Actinium Pharmaceuticals, Inc. (3)
- Acumen Pharmaceuticals, Inc. (1)
- Acurx Pharmaceuticals, LLC (1)
- Adagio Therapeutics, Inc. (1)
- Adhera Therapeutics, Inc. (1)
- ADMA BIOLOGICS, INC. (1)
- ADURO BIOTECH, INC. (2)
- Advaxis, Inc. (1)
- Adverum Biotechnologies, Inc. (2)
- Aeglea BioTherapeutics, Inc. (1)
- Aerovate Therapeutics, Inc. (1)
- AGENUS INC (3)
- AGIOS PHARMACEUTICALS INC (1)
- AILERON THERAPEUTICS INC (1)
- Aimmune Therapeutics, Inc. (1)
- Akebia Therapeutics, Inc. (2)
- Akero Therapeutics, Inc. (1)
- Akouos, Inc. (1)
- ALBIREO PHARMA, INC. (1)
- Alector, Inc. (1)
- Alexion Pharmaceuticals (1)
- Aligos Therapeutics, Inc. (1)
- Alkermes plc. (2)
- Allakos Inc. (1)
- Allena Pharmaceuticals, Inc. (1)
- Alliqua BioMedical, Inc. (3)
- Allogene Therapeutics, Inc. (1)
- Allovir, Inc. (2)
- ALNYLAM PHARMACEUTICALS, INC. (1)
- ALPINE IMMUNE SCIENCES, INC. (1)
- Altimmune, Inc. (1)
- ALX ONCOLOGY HOLDINGS INC (1)
- AMICUS THERAPEUTICS, INC. (3)
- Annexon, Inc. (1)
- Apellis Pharmaceuticals, Inc. (1)
- APPLIED GENETIC TECHNOLOGIES CORP (2)
- Applied Molecular Transport Inc. (1)
- Aprea Therapeutics, Inc. (1)
- AquaBounty Technologies, Inc. (2)
- AQUINOX PHARMACEUTICALS, INC (1)
- Aravive, Inc. (2)
- Arcellx, Inc. (1)
- Arcturus Therapeutics Holdings Inc. (1)
- Arcus Biosciences, Inc. (1)
- ARDELYX, INC. (1)
- ARENA PHARMACEUTICALS INC (2)
- Arsanis, Inc. (4)
- Artiva Biotherapeutics, Inc. (1)
- ARYA Sciences Acquisition Corp II (2)
- Atara Biotherapeutics, Inc. (1)
- Athenex, Inc. (1)
- ATHERSYS, INC (1)
- ATOSSA GENETICS INC (1)
- aTYR PHARMA INC (2)
- Aura Biosciences, Inc. (1)
- Avidity Biosciences, Inc. (1)
- AVROBIO, Inc. (1)
- Axcella Health Inc. (2)
- Axovant Sciences Ltd. (2)
- Ayala Pharmaceuticals, Inc. (1)
- AZIYO BIOLOGICS, INC. (1)
- AzurRx BioPharma, Inc. (1)
- BCTG Acquisition Corp. (2)
- Beam Therapeutics Inc. (1)
- BeiGene, Ltd. (1)
- BELLICUM PHARMACEUTICALS, INC (1)
- Big Cypress Acquisition Corp. (2)
- BIO-PATH HOLDINGS INC (1)
- BioAtla, Inc. (1)
- BioCardia, Inc. (3)
- BIOCEPT INC (1)
- Biogen Inc. (2)
- Biohaven Pharmaceutical Holding Co Ltd. (1)
- BIOMARIN PHARMACEUTICAL INC (1)
- Biomea Fusion, Inc. (2)
- BIOSPECIFICS TECHNOLOGIES CORP (1)
- Biostage, Inc. (1)
- BIOTIME INC (1)
- BioXcel Therapeutics, Inc. (1)
- Bison Capital Acquisition Corp. (2)
- Black Diamond Therapeutics, Inc. (2)
- Blue Water Vaccines Inc. (1)
- bluebird bio, Inc. (1)
- Bolt Biotherapeutics, Inc. (1)
- Bone Biologics Corp (1)
- BridgeBio Pharma, Inc. (3)
- C4 Therapeutics, Inc. (2)
- Cabaletta Bio, Inc. (2)
- CALADRIUS BIOSCIENCES, INC. (2)
- Calyxt, Inc. (2)
- CANCER GENETICS, INC (1)
- Candel Therapeutics, Inc. (1)
- CAPRICOR THERAPEUTICS, INC. (3)
- CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (2)
- Capstone Therapeutics Corp. (1)
- CareDx, Inc. (1)
- Caribou Biosciences, Inc. (1)
- CASI Pharmaceuticals, Inc. (1)
- CATABASIS PHARMACEUTICALS INC (1)
- CATALYST BIOSCIENCES, INC. (4)
- Celcuity Inc. (1)
- Cellectar Biosciences, Inc. (1)
- Cellular Biomedicine Group, Inc. (2)
- Century Therapeutics, Inc. (1)
- Chanticleer Holdings, Inc. (1)
- Chardan Healthcare Acquisition 2 Corp. (1)
- Chardan Healthcare Acquisition Corp. (3)
- Checkmate Pharmaceuticals, Inc. (2)
- ChemoCentryx, Inc. (2)
- Cibus Global, Ltd. (1)
- Cidara Therapeutics, Inc. (1)
- Clovis Oncology, Inc. (11)
- Codiak BioSciences, Inc. (4)
- CohBar, Inc. (1)
- Coherus BioSciences, Inc. (1)
- Comera Life Sciences Holdings, Inc. (1)
- Conatus Pharmaceuticals Inc. (2)
- CONCERT PHARMACEUTICALS, INC. (1)
- Consonance-HFW Acquisition Corp. (1)
- Constellation Alpha Capital Corp. (1)
- CONSTELLATION PHARMACEUTICALS INC (1)
- CONTRAFECT Corp (1)
- Cortexyme, Inc. (1)
- Crinetics Pharmaceuticals, Inc. (1)
- CTI BIOPHARMA CORP (1)
- Cue Biopharma, Inc. (1)
- Cullinan Oncology, LLC (2)
- CURIS INC (4)
- Cyclacel Pharmaceuticals, Inc. (2)
- CytoDyn Inc. (2)
- CytomX Therapeutics, Inc. (1)
- CYTORI THERAPEUTICS, INC. (1)
- CYTRX CORP (2)
- Day One Biopharmaceuticals Holding Co LLC (1)
- Decibel Therapeutics, Inc. (1)
- Deciphera Pharmaceuticals, Inc. (2)
- DelMar Pharmaceuticals, Inc. (2)
- Denali Therapeutics Inc. (1)
- Dermavant Sciences Ltd (1)
- DiaMedica Therapeutics Inc. (2)
- Dicerna Pharmaceuticals Inc (2)
- Diffusion Pharmaceuticals Inc. (3)
- DYNAVAX TECHNOLOGIES CORP (1)
- Dyne Therapeutics, Inc. (1)
- Eagle Pharmaceuticals, Inc. (1)
- Edge Therapeutics, Inc. (1)
- Eidos Therapeutics, Inc. (1)
- Eliem Therapeutics, Inc. (1)
- Emerald Bioscience, Inc. (1)
- Enanta Pharmaceuticals, Inc. (1)
- Entasis Therapeutics Holdings Inc. (1)
- Entrada Therapeutics, Inc. (2)
- ENZON PHARMACEUTICALS, INC. (1)
- Epizyme, Inc. (1)
- Erasca, Inc. (1)
- Esperion Therapeutics, Inc. (2)
- Evelo Biosciences, Inc. (1)
- EXICURE, INC. (1)
- FIVE PRIME THERAPEUTICS INC (1)
- Flex Pharma, Inc. (1)
- Foghorn Therapeutics Inc. (1)
- Forma Therapeutics Holdings, Inc., (1)
- Fortress Biotech, Inc. (2)
- Forty Seven, Inc. (1)
- Frequency Therapeutics, Inc. (1)
- FS Development Corp. (4)
- FS Development Corp. II (2)
- Fusion Pharmaceuticals Inc. (2)
- G1 Therapeutics, Inc. (1)
- Gain Therapeutics, Inc. (1)
- Galecto Inc. (2)
- Galera Therapeutics, Inc. (1)
- Gamida Cell Ltd. (1)
- Gemphire Therapeutics Inc. (2)
- GENELUX CORP (1)
- Generation Bio Co. (1)
- GENOCEA BIOSCIENCES, INC. (1)
- Global Blood Therapeutics, Inc. (1)
- GLYCOMIMETICS INC (1)
- Gossamer Bio, Inc. (1)
- Graphite Bio, Inc. (1)
- Greater Cannabis Company, Inc. (2)
- Greenwich LifeSciences, Inc. (1)
- Gritstone Oncology, Inc. (1)
- GT Biopharma, Inc. (1)
- GTX INC (1)
- HARBOR DIVERSIFIED, INC. (1)
- HCW Biologics Inc. (1)
- Health Sciences Acquisitions Corp (1)
- HEAT BIOLOGICS, INC. (1)
- HERON THERAPEUTICS, INC. (2)
- HilleVax, Inc. (1)
- Hillstream BioPharma Inc. (1)
- Homology Medicines, Inc. (1)
- HOOKIPA Pharma Inc. (2)
- iBio, Inc. (2)
- Icosavax, Inc. (1)
- IDEAYA Biosciences, Inc. (1)
- IDERA PHARMACEUTICALS, INC. (1)
- IGM Biosciences, Inc. (1)
- Imago BioSciences, Inc. (1)
- Immix Biopharma, Inc. (1)
- Immuneering Corp (1)
- ImmunoCellular Therapeutics, Ltd. (1)
- IMMUNOMEDICS INC (2)
- Inhibikase Therapeutics, Inc. (1)
- Inhibrx, Inc. (2)
- InMed Pharmaceuticals Inc. (1)
- INOVIO PHARMACEUTICALS, INC. (1)
- Inozyme Pharma, Inc. (1)
- INSMED Inc (1)
- Inspyr Therapeutics, Inc. (2)
- Instil Bio, Inc. (1)
- Intec Parent Inc. (1)
- Intellia Therapeutics, Inc. (1)
- INTERCEPT PHARMACEUTICALS, INC. (1)
- Invitae Corp (1)
- IOVANCE BIOTHERAPEUTICS, INC. (1)
- Isoray, Inc. (1)
- iTeos Therapeutics, Inc. (2)
- Jounce Therapeutics, Inc. (1)
- KalVista Pharmaceuticals, Inc. (1)
- Karuna Therapeutics, Inc. (2)
- Karyopharm Therapeutics Inc. (1)
- Kindred Biosciences, Inc. (1)
- Kinnate Biopharma Inc. (1)
- Kiromic Biopharma, Inc. (3)
- Kodiak Sciences Inc. (1)
- Krystal Biotech, Inc. (1)
- Kura Oncology, Inc. (1)
- Kymera Therapeutics, Inc. (1)
- LA JOLLA PHARMACEUTICAL CO (1)
- Lantern Pharma Inc. (1)
- Leisure Acquisition Corp. (1)
- LianBio (2)
- LifeSci Acquisition Corp. (2)
- LogicBio Therapeutics, Inc. (2)
- LONGEVERON LLC (1)
- Lyell Immunopharma, Inc. (1)
- MACROGENICS INC (1)
- MADRIGAL PHARMACEUTICALS, INC. (1)
- Magenta Therapeutics, Inc. (1)
- MAIA Biotechnology, Inc. (2)
- MARIZYME INC (9)
- Marker Therapeutics, Inc. (2)
- MATEON THERAPEUTICS INC (3)
- MAXCYTE, INC. (1)
- MEI Pharma, Inc. (1)
- MeiraGTx Holdings plc (1)
- MERRIMACK PHARMACEUTICALS INC (1)
- Mersana Therapeutics, Inc. (1)
- Millendo Therapeutics, Inc. (1)
- MiMedx Group, Inc. (1)
- Minerva Neurosciences, Inc. (1)
- MiNK Therapeutics, Inc. (1)
- MIRAGEN THERAPEUTICS, INC. (1)
- Mirum Pharmaceuticals, Inc. (1)
- Moderna, Inc. (1)
- Molecular Templates, Inc. (3)
- Moleculin Biotech, Inc. (1)
- Monte Rosa Therapeutics, Inc. (2)
- Myovant Sciences Ltd. (1)
- Myriad Genetics, Inc. (4)
- NantKwest, Inc. (1)
- Natera, Inc. (2)
- NEUROTROPE BIOSCIENCE, INC. (1)
- NexImmune, Inc. (1)
- NextCure, Inc. (1)
- Nkarta, Inc. (1)
- Novus Therapeutics, Inc. (2)
- NTN BUZZTIME INC (8)
- Nuvalent, Inc. (2)
- Olema Pharmaceuticals, Inc. (1)
- Olivia Ventures, Inc. (3)
- Omega Therapeutics, Inc. (1)
- Oncorus, Inc. (1)
- ONCOSEC MEDICAL Inc (1)
- OPGEN INC (1)
- Ophthotech Corp. (1)
- Opko Health, Inc. (2)
- Oric Pharmaceuticals, Inc. (1)
- Oyster Point Pharma, Inc. (1)
- Pasithea Therapeutics Corp. (1)
- Passage BIO, Inc. (1)
- PDL BIOPHARMA, INC. (2)
- PepGen Inc. (1)
- Pfenex Inc. (1)
- PhaseBio Pharmaceuticals Inc (1)
- PIERIS PHARMACEUTICALS, INC. (1)
- PLURISTEM THERAPEUTICS INC (1)
- PMV Pharmaceuticals, Inc. (1)
- POLARITYTE, INC. (2)
- Praxis Precision Medicines, Inc. (3)
- PRECISION BIOSCIENCES INC (1)
- Principia Biopharma Inc. (1)
- Progenics Pharmaceuticals, Inc. (1)
- PROGENITY, INC. (2)
- Prometheus Biosciences, Inc. (1)
- Propanc Biopharma, Inc. (2)
- PROTEON THERAPEUTICS INC (9)
- PROTEOSTASIS THERAPEUTICS, INC. (2)
- Prothena Corp plc (1)
- PUMA BIOTECHNOLOGY, INC. (1)
- Pyxis Oncology, Inc. (1)
- Radius Health, Inc. (2)
- Rallybio Corp (1)
- RAPT Therapeutics, Inc. (1)
- RECURSION PHARMACEUTICALS, INC. (1)
- Relay Therapeutics, Inc. (1)
- RenovoRx, Inc. (2)
- Revolution Medicines, Inc. (1)
- REXAHN PHARMACEUTICALS, INC. (1)
- RHYTHM PHARMACEUTICALS, INC. (1)
- RITTER PHARMACEUTICALS INC (2)
- ROCKET PHARMACEUTICALS, INC. (4)
- Sage Therapeutics, Inc. (2)
- Sana Biotechnology, Inc. (1)
- SANGAMO THERAPEUTICS, INC (1)
- Sarepta Therapeutics, Inc. (1)
- Sensei Biotherapeutics, Inc. (1)
- SERA PROGNOSTICS, INC. (1)
- Seres Therapeutics, Inc. (2)
- Sesen Bio, Inc. (7)
- Shattuck Labs, Inc. (1)
- Social Capital Suvretta Holdings Corp. III (1)
- SOLENO THERAPEUTICS INC (1)
- Solid Biosciences Inc. (1)
- SOPHIRIS BIO INC. (1)
- Sorrento Therapeutics, Inc. (1)
- Spectrum Pharmaceuticals, Inc. (1)
- Spero Therapeutics, Inc. (1)
- SPHERIX INC (4)
- Spring Bank Pharmaceuticals, Inc. (2)
- SpringWorks Therapeutics, Inc. (2)
- SPRUCE BIOSCIENCES, INC. (1)
- SQZ Biotechnologies Co (1)
- Stellar Biotechnologies, Inc. (1)
- Stoke Therapeutics, Inc. (1)
- Sun BioPharma, Inc. (1)
- Syndax Pharmaceuticals Inc (2)
- SYNLOGIC, INC. (1)
- T2 Biosystems, Inc. (1)
- Talaris Therapeutics, Inc. (1)
- Taysha Gene Therapies, Inc. (1)
- TCR2 THERAPEUTICS INC. (2)
- TENAX THERAPEUTICS, INC. (1)
- Tenaya Therapeutics, Inc. (1)
- Therapeutics Acquisition Corp. (1)
- Transcode Therapeutics, Inc. (2)
- Translate Bio, Inc. (1)
- Trovagene, Inc. (2)
- TScan Therapeutics, Inc. (1)
- Twist Bioscience Corp (1)
- TYME TECHNOLOGIES, INC. (1)
- Tyra Biosciences, Inc. (1)
- Ultragenyx Pharmaceutical Inc. (1)
- United Therapeutics Corp (2)
- Unity Biotechnology, Inc. (1)
- Unum Therapeutics Inc. (3)
- VACCINEX, INC. (1)
- Vaccitech plc (1)
- Vanda Pharmaceuticals Inc. (1)
- Vaxart, Inc. (7)
- Vaxcyte, Inc. (1)
- Vaxxinity, Inc. (1)
- Vera Therapeutics, Inc. (1)
- VERACYTE, INC. (1)
- Verastem, Inc. (2)
- Verve Therapeutics, Inc. (1)
- VICAL INC (2)
- Viela Bio, Inc. (1)
- Vigil Neuroscience, Inc. (1)
- Viking Therapeutics, Inc. (1)
- VistaGen Therapeutics, Inc. (16)
- VITAL THERAPIES INC (2)
- Vor Biopharma Inc. (1)
- Voyager Therapeutics, Inc. (2)
- vTv Therapeutics Inc. (1)
- Werewolf Therapeutics, Inc. (1)
- WINDTREE THERAPEUTICS INC (4)
- Xenon Pharmaceuticals Inc. (1)
- Xilio Therapeutics, Inc. (1)
- XOMA Corp (4)
- ZAFGEN, INC. (3)
- Zentalis Pharmaceuticals, LLC (2)
- Form of Indemnification Agreement (Chardan Healthcare Acquisition Corp., Filed With SEC on May 15, 2023)
- Form of Indemnification Agreement for Directors and Officers (Zentalis Pharmaceuticals, LLC, Filed With SEC on May 10, 2023)
- Form of Indemnification Agreement by and between the Company and its directors and executive officers (VICAL INC, Filed With SEC on March 30, 2023)
- Form of Indemnification Agreement for Directors and Officers of Carisma Therapeutics Inc (Sesen Bio, Inc., Filed With SEC on March 8, 2023)
- Form of Indemnification Agreement for directors (Cyclacel Pharmaceuticals, Inc., Filed With SEC on March 8, 2023)
- Form of Indemnification Agreement for Directors of Disc Medicine, Inc (FS Development Corp., Filed With SEC on December 29, 2022)
- Form of Indemnification Agreement for Officers of Disc Medicine, Inc (FS Development Corp., Filed With SEC on December 29, 2022)
- Form of Director and Officer Indemnification Agreement (AMICUS THERAPEUTICS, INC., Filed With SEC on December 28, 2022)
- Catalyst Biosciences, Inc. Form of Director Indemnification Agreement (CATALYST BIOSCIENCES, INC., Filed With SEC on December 27, 2022)
- Form of Indemnification Agreement (Lucy Lu) (Fortress Biotech, Inc., Filed With SEC on December 19, 2022)
- Form of Indemnification Agreement (Cellectar Biosciences, Inc., Filed With SEC on December 2, 2022)
- Form of Indemnification Agreement between the Registrant and each of its directors and officers (Vaccitech plc, Filed With SEC on November 10, 2022)
- Form of Indemnification Agreement between Marizyme, Inc. and each current officer or director (MARIZYME INC, Filed With SEC on November 2, 2022)
- Form of Indemnification Agreement between the Company and each of its directors and officers (CALADRIUS BIOSCIENCES, INC., Filed With SEC on September 15, 2022)
- Form of Indemnification Agreement for directors and executive officers of the registrant (BIOTIME INC, Filed With SEC on August 11, 2022)
- Indemnification Agreement, dated May 13, 2022, by and between VistaGen Therapeutics, Inc. and Reid G. Adler J.D (VistaGen Therapeutics, Inc., Filed With SEC on August 11, 2022)
- Form of Indemnification Agreement (MAIA Biotechnology, Inc., Filed With SEC on August 1, 2022)
- Form of Indemnification Agreement, dated as of July 11, 2022, by and among ProKidney Corp. and its directors and executive officers (Social Capital Suvretta Holdings Corp. III, Filed With SEC on July 15, 2022)
- Form of Indemnification Agreement by and between the registrant and its directors and executive officers (GENELUX CORP, Filed With SEC on June 24, 2022)
- Form of Indemnification Agreement with directors and executive officers (Axovant Sciences Ltd., Filed With SEC on June 14, 2022)
- Form of Director and Officer Indemnification Agreement (Comera Life Sciences Holdings, Inc., Filed With SEC on May 25, 2022)
- Form of Indemnification and Advancement Agreement for Directors and Officers (Biomea Fusion, Inc., Filed With SEC on May 16, 2022)
- Form of Indemnification Agreement (AzurRx BioPharma, Inc., Filed With SEC on May 5, 2022)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (PepGen Inc., Filed With SEC on May 2, 2022)
- Form of Indemnification Agreement by and between Tyme Technologies, Inc. and its individual directors and officers (TYME TECHNOLOGIES, INC., Filed With SEC on April 29, 2022)
- Form of Indemnification Agreement (ENZON PHARMACEUTICALS, INC., Filed With SEC on April 26, 2022)
- Form of Indemnification Agreement between the Company and each of its directors and executive officers (MAIA Biotechnology, Inc., Filed With SEC on April 11, 2022)
- Form of Indemnification Agreement for Directors and Officers (HilleVax, Inc., Filed With SEC on April 6, 2022)
- Indemnification Agreement dated November 1, 2020 with Bruce Harmon (MARIZYME INC, Filed With SEC on March 31, 2022)
- Indemnification Agreement dated November 1, 2020 with James Sapirstein (MARIZYME INC, Filed With SEC on March 31, 2022)
- Form of Indemnification Agreement (Gamida Cell Ltd., Filed With SEC on March 24, 2022)
- Form of Director and Officer Indemnification Agreement (Unum Therapeutics Inc., Filed With SEC on March 15, 2022)
- Form of Indemnification Agreement by and between Sesen Bio, Inc. and Each of its Directors and Executive Officers (Sesen Bio, Inc., Filed With SEC on February 28, 2022)
- Indemnification Agreement effective as of February 14, 2022, by and between Kiromic BioPharma, Inc. and Daniel Clark (Kiromic Biopharma, Inc., Filed With SEC on February 16, 2022)
- Indemnification Agreement effective as of January 27, 2022 by and between Kiromic BioPharma, Inc. and Pietro Bersani (Kiromic Biopharma, Inc., Filed With SEC on February 2, 2022)
- Form of Director Indemnification Agreement (CAPSTAR SPECIAL PURPOSE ACQUISITION CORP., Filed With SEC on January 20, 2022)
- Form of Officer Indemnification Agreement (CAPSTAR SPECIAL PURPOSE ACQUISITION CORP., Filed With SEC on January 20, 2022)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Arcellx, Inc., Filed With SEC on January 14, 2022)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Vigil Neuroscience, Inc., Filed With SEC on January 3, 2022)
- Form of Indemnification Agreement for Directors of Pardes Biosciences, Inc (FS Development Corp. II, Filed With SEC on December 30, 2021)
